559 related articles for article (PubMed ID: 26853626)
1. Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity.
Shimada K; Hayano M; Pagano NC; Stockwell BR
Cell Chem Biol; 2016 Feb; 23(2):225-235. PubMed ID: 26853626
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
[TBL] [Abstract][Full Text] [Related]
3. Optimal drug prediction from personal genomics profiles.
Sheng J; Li F; Wong ST
IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
[TBL] [Abstract][Full Text] [Related]
4. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
Nishiyama M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome modeling and phenotypic assays for cancer precision medicine.
Jeong E; Moon SU; Song M; Yoon S
Arch Pharm Res; 2017 Aug; 40(8):906-914. PubMed ID: 28766239
[TBL] [Abstract][Full Text] [Related]
6. High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways.
Warchal SJ; Dawson JC; Shepherd E; Munro AF; Hughes RE; Makda A; Carragher NO
Bioorg Med Chem; 2020 Jan; 28(1):115209. PubMed ID: 31757681
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
9. Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning.
Miao R; Chen HH; Dang Q; Xia LY; Yang ZY; He MF; Hao ZF; Liang Y
Pharmacol Res; 2020 Sep; 159():104932. PubMed ID: 32473309
[TBL] [Abstract][Full Text] [Related]
10. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
Cavic M; Krivokuca A; Boljevic I; Brotto K; Jovanovic K; Tanic M; Filipovic L; Zec M; Malisic E; Jankovic R; Radulovic S
J BUON; 2016; 21(5):1287-1295. PubMed ID: 27837635
[TBL] [Abstract][Full Text] [Related]
12. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
Covell DG
PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
[TBL] [Abstract][Full Text] [Related]
13. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
[TBL] [Abstract][Full Text] [Related]
14. Biomarker identification for statin sensitivity of cancer cell lines.
Raghu VK; Beckwitt CH; Warita K; Wells A; Benos PV; Oltvai ZN
Biochem Biophys Res Commun; 2018 Jan; 495(1):659-665. PubMed ID: 29146185
[TBL] [Abstract][Full Text] [Related]
15. Comparison and validation of genomic predictors for anticancer drug sensitivity.
Papillon-Cavanagh S; De Jay N; Hachem N; Olsen C; Bontempi G; Aerts HJ; Quackenbush J; Haibe-Kains B
J Am Med Inform Assoc; 2013; 20(4):597-602. PubMed ID: 23355484
[TBL] [Abstract][Full Text] [Related]
16. Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine.
Kim HS; Sung YJ; Paik S
Yonsei Med J; 2015 Sep; 56(5):1186-98. PubMed ID: 26256959
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer.
Garcia-Alonso L; Iorio F; Matchan A; Fonseca N; Jaaks P; Peat G; Pignatelli M; Falcone F; Benes CH; Dunham I; Bignell G; McDade SS; Garnett MJ; Saez-Rodriguez J
Cancer Res; 2018 Feb; 78(3):769-780. PubMed ID: 29229604
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies.
Calvo E; Walko C; Dees EC; Valenzuela B
Am Soc Clin Oncol Educ Book; 2016; 35():e175-84. PubMed ID: 27249721
[TBL] [Abstract][Full Text] [Related]
19. Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
Safikhani Z; Smirnov P; Thu KL; Silvester J; El-Hachem N; Quevedo R; Lupien M; Mak TW; Cescon D; Haibe-Kains B
Nat Commun; 2017 Oct; 8(1):1126. PubMed ID: 29066719
[TBL] [Abstract][Full Text] [Related]
20. Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells.
Abrams RP; Carroll WL; Woerpel KA
ACS Chem Biol; 2016 May; 11(5):1305-12. PubMed ID: 26797166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
